MIMEDX Addresses Presentation by Prescience Point
globenewswire.com
news
2022-06-02 00:00:00

Company Highlights Factually Accurate Information Already Provided Urges Shareholders to Vote 'FOR' MIMEDX's Highly Qualified and Independent Directors â€“ James L. Bierman and Phyllis Gardner, M.D. On the WHITE Proxy Card Today MARIETTA, Ga., June 02, 2022 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (NASDAQ: MDXG) ('MIMEDX' or the 'Company'), a transformational placental biologics company, today addressed the highly misleading presentation published by Prescience Point on May 31, 2022, which mischaracterizes important facts and relies on outdated and irrelevant information.
